Innovative Medical Services Acquires Revolutionary, Safe Pesticide Technology; Timing is Key: Leading Brands Banned by EPA because of Toxicity.

Business Editors and Health/Medical Writers

SAN DIEGO--(BW HealthWire)--Jan. 8, 2001

Innovative Medical Services (NASDAQ:PURE) Monday announced it has acquired a revolutionary, safe pesticide technology.

Developed by Dr. Gerald Weaver, San Diego, the new "bait station" style pesticide contain a familiar active ingredient, boric acid, bound to a masking agent and combined with an attractant fragrance and proteins in a colloidal suspension. The patent-pending time-released formulation protects the boric acid from dissolving in water and maintains the integrity of the pesticide to obtain maximum killing effect. The product line, containing particular formulas for specific pests, provides excellent results against cockroaches, ants, palmetto bugs, silverfish, waterbugs, ticks, fleas, lice and garden pests. Dr. Weaver has accepted a position with Innovative Medical Services and will serve as Senior Scientist to head research and development for the company's new Integrated Pest Management Division.

Dr. Weaver stated, "With my technology and Innovative Medical Services' expert marketing and extensive lines of distribution, no one should ever again have to live in an infested environment. Joining the IMS team allows me to focus on my continuing research to develop safe pest control weapons to help combat the increasing health problems found extensively in children caused by pest infestation and toxic pesticides."

The EPA-approved RoachX will be the first product to launch from the line. RoachX is over 96% effective in three to four days with one application for indoor/outdoor eradication of cockroaches. RoachX is currently used exclusively by the San Diego Unified School District, as well as the by other San Diego County school districts including Chula Vista, San Ysidro, Spring Valley and La Mesa.

Innovative Medical Services sees a key window of opportunity to launch these new products. On June 8, 2000, the United States EPA banned the Dow Chemical product Dursban (also sold as Lorsban). Over 800 products containing the organophosphate pesticide chlorpyrifos are banned. Sales of such products to retailers ends Feb. 1, 2001, and retailers must remove the products from shelves by Dec. 31, 2001. The most familiar of the products currently containing the banned chemical include: Raid, Combat, Hot Shot, Ortho and Real Kill, including all sprays and foggers. The current formulations are also banned for commercial and agriculture professionals as of Dec. 31, 2000. Professional pest control companies must use a 100 to 1 diluted version of the current product strength and obtain a waiver of responsibility from the home or business owner. By June 6, 2001, the product must undergo a further 10 to 1 dilution, creating a 1000 to 1 diluted treatment that is essentially ineffective.

Larry Lucas, Innovative Medical Services' Vice President of Sales, commented, "I'm excited to add another top-notch, health-conscious product to our growing product line. More and more, consumers seek alternatives to harsh poisons currently available for pest control. Because of the push for safe, environmentally-friendly products and the recent ban of currently available products, the timing couldn't be better for us to get RoachX on retail shelves and in commercial use across the nation."

Boric acid is registered as a Class III pesticide. Class I and Class II are toxic, restricted use pesticides. Within Category III, the EPA rates pesticides on a scale of one to 10, with one being the least toxic. Boric acid is rated at minus one (-1). Although toxic to the target pest, boric acid is safe for use near children and domestic animals when used as directed and is harmless to the environment.

About Innovative Medical Services

Innovative Medical Services, based in El Cajon, Calif., is the nation's leader in pharmaceutical water purification. The company has expanded from its niche pharmacy market into other, broader markets with new products, including residential and commercial water filtration systems, health and wellness-related retail merchandise, silver ion bioscience technologies in addition to the company's comprehensive e-commerce health supersite, www.Nutripure.com.

Forward-looking statements in this release are made pursuant to the "safe harbor" provisions of the Private Securities Litigation Reform Act of 1995. Forward-looking statements are based on current management expectations that involve risks and uncertainties that may result in such expectations not being realized. Potential risks and uncertainties include, but are not limited to, the risks described in filings with the Securities and Exchange Commission.